Abiomed Operating Income

Abiomed (ABMD) currently reports a operating income of $250M as of September 2022. That compares with $260M in the prior-year period — down 2.6% year over year. Use the charts on this page to explore Abiomed's operating income history and peer comparisons.

Abiomed's operating income decreased from $260M to $250M — a 2.6% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Abiomed reported $250M in operating income as of September 2022. That compares with $260M in the prior-year period — down 2.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $250M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Abiomed, and consider following ABMD for alerts when major investors trade the stock.

Abiomed is classified in the Healthcare sector. On operating income, it currently shows $250M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ABMD with unrelated industries.